Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- Status
- RECRUITING
- Phase
- NA
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
GEN1046 Safety and PK in Subjects With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ECP-1014 Treatment for Patients With Solid Tumor Cancers
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of CBP-1018 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Medical Treatment of Solid Tumors at the Lyon University Hospital Cancer Institute During the First Wave of COVID-19 in France: A Conservative Approach
- Status
- COMPLETED
- Phase
- N/A
A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Study of DT2216 in Relapsed/Refractory Malignancies
- Status
- COMPLETED
- Phase
- PHASE1